Clinical Trials Sponsored by Special X Inc.

Total 141 results

University of Oregon
Special X Inc.

Recruiting

FASTT Telehealth Behavioral Support Service for Caregivers of Children With Developmental Delay or Disability (FASTT)

Parent-Child Relations | Parenting | Child Behavior | Developmental Disability | Development Delay | Development Disorder, Child

United States
On-X Life Technologies, Inc.

Terminated

On-X Heart Valve - 17mm Aortic and 23mm Mitral

Heart Valve Disease

United States, Puerto Rico, Spain
On-X Life Technologies, Inc.

Completed

Prospective Randomized On-X Versus SJM Evaluation Trial (PROSE)

Heart Valve Disease

United States, Canada, Netherlands, India, Australia, Germany, Norway, South Africa, Sweden
Special Therapies, Inc.

Completed

Craniosacral Therapy for Concussion Symptoms

Post-Concussion Syndrome

United States
On-X Life Technologies, Inc.
North American Science Associates Inc.

Active, not recruiting

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

Thrombotic and Bleeding Events

United States, Canada, United Kingdom
Gemin X

Completed

Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)

Lymphoma, Follicular

United States
Gemin X

Completed

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

AML

United States, Canada
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer

Lung Cancer

United States
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Mantle-Cell Lymphoma

United States
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

Hematological Malignancies

United States, Canada
Gemin X

Withdrawn

Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas

Solid Tumors and Lymphomas
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

Canada, United States
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia

Myelofibrosis

United States, Canada
Gemin X

Terminated

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Metastatic Melanoma

United States
Gemin X

Completed

A Phase I/II Study of GX15-070MS in Untreated CLL

Chronic Lymphocytic Leukemia

United States, Canada
Gemin X
Cephalon

Completed

A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Extensive-stage Small Cell Lung Cancer

Canada, United States, United Kingdom, Serbia, Bulgaria, India, Hungary, Czech Republic, Poland, Romania
Clinic for Special Children
Genentech, Inc.

Active, not recruiting

Risdiplam in Patients With Spinal Muscular Atrophy Previously Treated With Nusinersen (RISE)

Spinal Muscular Atrophy

United States
Spectral Diagnostics (US) Inc.

Recruiting

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study (TIGRIS)

Septic Shock | Endotoxemia

United States
Spectral Diagnostics (US) Inc.

No longer available

Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19

Septic Shock | Endotoxemia | COVID | Corona Virus Infection | Sepsis, Severe

United States
Spectral Diagnostics (US) Inc.

Temporarily not available

Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock (EUPHORIA)

Septic Shock | Endotoxemia
Spectral Diagnostics (US) Inc.

Completed

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock (EUPHRATES)

Septic Shock | Endotoxemia

United States, Canada
Hospital for Special Surgery, New York
Orthosensor, Inc.

Withdrawn

TKR With and Without the Use of Intra-operative Sensing

Osteoarthritis

United States
Hospital for Special Surgery, New York
Genentech, Inc.

Completed

Study of Tocilizumab to Treat Polymyalgia Rheumatica

Polymyalgia Rheumatica (PMR)

United States
Hospital for Special Surgery, New York
Genentech, Inc.

Completed

A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (RITAPS)

Antiphospholipid Syndrome

United States
Hospital for Special Surgery, New York
Ethicon, Inc.

Completed

The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery

Osteoarthritis

United States
On-X Life Technologies, Inc.
Clinipace Worldwide; Avania; Acelis Connected Health; WCG IRB

Active, not recruiting

Randomized On-X Anticoagulation Trial (PROACT)

Heart Valve Disease

United States, Canada
Viatris Specialty LLC

Completed

Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience

Abuse Potential

United States
Viatris Specialty LLC

Completed

Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users

Abuse Potential

United States
Mylan Specialty, LP

Terminated

Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning

Liver Failure | Amatoxin Poisoning | Amanita Poisoning | Mushroom Poisoning

United States
Hospital for Special Surgery, New York
Auxilium Pharmaceuticals, Inc.

Completed

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Dupuytren's Disease

United States
Mylan Specialty, LP

Recruiting

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Pain | Acute Pain | Post Operative Pain

United States
Mylan Specialty, LP

Recruiting

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Pain | Acute Pain | Post Operative Pain

United States
Viatris Specialty LLC

Completed

Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users

Abuse Potential

United States
Mylan Specialty, LP

Completed

Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.

Pain | Acute Pain | Post Operative Pain

United States
7D Surgical Inc.
Hospital for Special Surgery, New York

Completed

Evaluation of 3D Machine-vision Image Guided Surgery Spine Navigation

Spondylolisthesis | Spinal Stenosis, Lumbar Region

United States
Hospital for Special Surgery, New York
Conventus Orthopaedics, Inc.

Completed

Volar Plate vs. Conventus DRS Fixation

Fractures, Closed

United States
MiMedx Group, Inc.
Hospital for Special Surgery, New York

Completed

dHACM in Lumbar Decompression and Microdiscectomy Surgery

Spinal Stenosis | Herniated Disc | Scarring

United States
Hospital for Special Surgery, New York
Human Genome Sciences Inc.

Completed

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Systemic Sclerosis

United States
Hospital for Special Surgery, New York
Roche Pharma AG; Genentech, Inc.

Terminated

Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (RENTGPA)

Granulomatosis With Polyangiitis (Wegener's Granulomatosis)

United States
Robert Hotchkiss
Auxilium Pharmaceuticals, Inc.

Unknown

Validation of Two New Questionnaires for Dupuytren's Disease

Dupuytren's Disease

United States
Gillette Children's Specialty Healthcare
Lite Run Inc.

Completed

Post-operative Lite Run Study

Cerebral Palsy | Neurologic Disorder | Spina Bifida | Chromosome Abnormality

United States
Mathematica Policy Research, Inc.
Social Security Administration

Recruiting

Ohio RETAIN Impact Evaluation

Disability

United States
Mathematica Policy Research, Inc.
Social Security Administration

Recruiting

Vermont RETAIN Impact Evaluation

Disability

United States
Sheidow Consulting, Inc.
Oregon Social Learning Center

Completed

Web-Based Contingency Management Training for Addictions (CM-TSS)

Substance Abuse Problem

United States
Health Resources in Action, Inc.
Methodist Healthcare Ministries of South Texas, Inc.; Social Innovation Fund

Completed

Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border

Depression | Hypertension | Obesity | Diabetes | Chronic Disease | Hypercholesterolemia | Mental Illness Persistent
Health Resources in Action, Inc.
Methodist Healthcare Ministries of South Texas, Inc.; Social Innovation Fund

Completed

Sí Texas Hope Family Health Center

Depression | Hypertension | Obesity | Diabetes | Chronic Disease | Hypercholesterolemia
MicroPort Orthopedics Inc.
Orthopaedic Specialty Clinic of Spokane, PLLC

Completed

Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis

Joint Disease

United States
SFJ Pharmaceuticals X, LTD.
Merck KGaA, Darmstadt, Germany; AIO-Studien-gGmbH; Academic and Community Cancer... and other collaborators

Withdrawn

Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer. (AMELION)

Metastatic Colorectal Cancer
McNeil Consumer & Specialty Pharmaceuticals, a...

Completed

A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

Clinical Trials Sponsored by Special X Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations